Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?

Area of Science:

• Phytomedicine and Tropical Diseases
• Pharmacology and Drug Development
• Traditional Chinese Medicine

Background:

• Artemisinin-based combination therapies (ACTs) are the primary treatment for malaria.
• Artemisia annua (A. annua) has a long history of traditional use for treating fevers.
• The complex chemical matrix of A. annua leaves may influence artemisinin's bioavailability and efficacy.

Purpose of the Study:

• To evaluate the therapeutic potential of A. annua dried leaves as an affordable malaria treatment.
• To investigate the pharmacokinetic advantages of A. annua leaf administration compared to pure artemisinin.
• To explore the role of co-administered plant compounds in artemisinin's efficacy and resistance management.

Main Methods:

• Comparative pharmacokinetic studies in rodents (healthy vs. Plasmodium chabaudi-infected mice).
• Analysis of artemisinin and deoxyartemisinin pharmacokinetics following A. annua leaf or pure artemisinin administration.
• Review of human trial data on artemisinin dosage requirements with dried A. annua leaves versus pure artemisinin.

Main Results:

• A. annua dried leaves significantly increased artemisinin's half-life (T1/2), time to maximum concentration (Tmax), maximum concentration (Cmax), and area under the curve (AUC) in infected mice.
• Artemisinin serum levels were over 40-fold higher in mice fed dried leaves compared to those fed pure artemisinin.
• Human trials indicated a 40-fold reduction in required artemisinin dosage when administered as dried leaves.

Conclusions:

• A. annua dried leaves offer enhanced artemisinin bioavailability and therapeutic response, requiring significantly lower doses.
• The cost-effectiveness and historical efficacy against drug resistance position A. annua leaf tablets as a valuable tool against malaria.
• Integrating affordable A. annua dried leaf tablets into malaria treatment strategies is recommended.